Operator of a biotech company intended to discover, develop, manufacture, and commercialize novel curative genomic medicine. The company is focused on transforming a viral-free genome surgery platform that enables the insertion of any genetic sequence of all sizes at any location into the human genome of disease-relevant cells, enabling medical professionals to treat severe genetic disease and cancer with ease.